We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTG icon
2351
MGIC Investment
MTG
$6.34B
$2K ﹤0.01%
+180
New +$2.5K
ACH
2352
Accendra Health
ACH
$247M
$2K ﹤0.01%
574
-155
-21% -$995
PULM icon
2353
Pulmatrix
PULM
$6.32M
$2K ﹤0.01%
130
– –
RDNT icon
2354
RadNet
RDNT
$4.84B
$2K ﹤0.01%
+146
New +$2.5K
RES icon
2355
RPC Inc
RES
$1.21B
$2K ﹤0.01%
439
-9,000
-95% -$40.4K
RRGB icon
2356
Red Robin
RRGB
$136M
$2K ﹤0.01%
88
-49
-36% -$1.45K
RRX icon
2357
Regal Rexnord
RRX
$14B
$2K ﹤0.01%
+34
New +$2.7K
SRDX
2358
DELISTED
Surmodics
SRDX
$2K ﹤0.01%
53
– –
TEX icon
2359
Terex
TEX
$7.89B
$2K ﹤0.01%
94
-692
-88% -$19.4K
TG icon
2360
Tredegar Corp
TG
$260M
$2K ﹤0.01%
110
– –
TRS icon
2361
TriMas Corp
TRS
$1.45B
$2K ﹤0.01%
+79
New +$2.44K
UNFI icon
2362
United Natural Foods
UNFI
$2.97B
$2K ﹤0.01%
246
– –
UTHR icon
2363
United Therapeutics
UTHR
$26.3B
$2K ﹤0.01%
24
-14
-37% -$1.23K
VAW icon
2364
Vanguard Materials ETF
VAW
$3.01B
$2K ﹤0.01%
+20
New +$2.58K
VTLE
2365
DELISTED
Vital Energy
VTLE
$2K ﹤0.01%
47
– –
WASH icon
2366
Washington Trust Bancorp
WASH
$736M
$2K ﹤0.01%
47
– –
WRLD icon
2367
World Acceptance Corp
WRLD
$909M
$2K ﹤0.01%
30
– –
WSR
2368
DELISTED
Whitestone REIT
WSR
$2K ﹤0.01%
203
– –
CHUY
2369
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$2K ﹤0.01%
115
– –
TARO
2370
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2K ﹤0.01%
24
– –
ROCC
2371
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2K ﹤0.01%
81
– –
AIMC
2372
DELISTED
Altra Industrial Motion Corp
AIMC
$2K ﹤0.01%
+67
New +$2.13K
ZNH
2373
DELISTED
China Southern Airlines Company Limited
ZNH
$2K ﹤0.01%
66
– –
VIVO
2374
DELISTED
Meridian Bioscience Inc
VIVO
$2K ﹤0.01%
296
-744
-72% -$6.99K
SAFM
2375
DELISTED
Sanderson Farms Inc
SAFM
$2K ﹤0.01%
+12
New +$1.9K
93 94
95
96 97

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.